Clearwater Capital Advisors, LLC Invitae Corp Transaction History

Clearwater Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	BUY	$6.28 - $15.59 $64,269 - $159,548	10,234 New	10,234 $82,000
Q4 2021 Jan 26, 2022	SELL	$14.7 - $28.67 $114,983 - $224,256	-7,822 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$24.31 - $33.6 $34,617 - $47,846	1,424 Added 22.26%	7,822 $222,000
Q2 2021 Aug 04, 2021	BUY	$26.09 - $40.4 $7,513 - $11,635	288 Added 4.71%	6,398 $216,000
Q1 2021 Apr 21, 2021	BUY	$33.06 - $56.93 $201,996 - $347,842	6,110 New	6,110 $233,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Clearwater Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearwater Capital Advisors, LLC with notifications on news.